Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Forte Bioscience Pop; Astrazeneca Reports; Paramount-Warner Latest | Stock Movers
Posted
July 27, 2026
Views
202
Likes
11
Comments
1
Engagement
July 27, 2026
202
11
1
5.94%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
4:07Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines.
- Astrazeneca (AZN) shares after it reported higher-than-expected profit, buoyed by blockbuster cancer medicines, with earnings per share rising 21% to $2.63 last quarter.
- Paramount Skydance (PSKY) shares are reacting to news that it paused its blockbuster deal for Warner Bros.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Forte Bioscience Pop; Astrazeneca Reports; Paramount-Warner Latest
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
